A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
Clinical trial NCT01702558 · TERMINATED
Trial details
- NCT number
- NCT01702558
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-03
- Primary completion
- 2017-05-31
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.